Additionally, compound 231 exerted antiproliferative effects on various cancer cell lines, including an ER-negative breast cancer cell line, suggesting that it is capable of suppressing the growth of cancer cells independent of its ER-modulating activity [217]. The gene discussed is ESR1; the disease is cancer.